Based on a study that included 50 patients with medullary thyroid cancer harboring RET M918T mutation in the tumor tissue, Cote et al. demonstrated that detection of RET M918T cfDNA by liquid biopsy strongly correlated with worse overall survival and predicted an outcome more accurately than calcitonin doubling time (41). Here, RET is linked to neoplasm.